Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | CDC25B | P30305 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | S100A4 | P26447 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | APAF1 | O14727 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18243404 | 0.75 | PPIA (0.33) | GPR3HTR2ANCOR2HDAC3HDAC4 | |
| SCHEMBL40599 | 0.75 | GPR3 (0.52) | GPR3HTR2ANCOR2HDAC3HDAC4 | |
| SCHEMBL18242520 | 0.75 | PPIA (0.49) | CA1CA2 | |
| SCHEMBL29641604 | 0.75 | GPR3 (0.52) | GPR3HTR2ANCOR2HDAC3HDAC4 | |
| SCHEMBL18242146 | 0.75 | HTR7 (0.41) | KMT2AMEN1KDM4ELMNAHTT | |
| SCHEMBL524603 | 0.73 | GPR3 (0.50) | GPR3HTR2ANCOR2HDAC3HDAC4 | |
| SCHEMBL29950614 | 0.73 | GPR3 (0.50) | GPR3HTR2ANCOR2HDAC3HDAC4 | |
| SCHEMBL5593897 | 0.73 | POLB (0.52) | NCOR2HDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL825558 | 0.71 | HTR2A (0.55) | GPR3HTR2ANCOR2HDAC3HDAC4 | |
| SCHEMBL1107108 | 0.71 | GPR3 (0.48) | GPR3HTR2ANCOR2HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 843 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114276372-A | Boron-containing condensed ring compound for OLED light-emitting layer and application thereof | 江苏三月科技股份有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-107963972-B | Organic electroluminescent device | 保土谷化学工业株式会社 | 2021-09-03 | — | — | CN | claimed |
| US-10745372-B2 | Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-08-18 | — | — | US | claimed |
| CN-111377847-A | Heterocyclic compound, composition comprising the same, and organic light-emitting device comprising the heterocyclic compound | 三星电子株式会社 | 2020-07-07 | — | — | CN | claimed |
| EP-2545024-B1 | PROCESS FOR PREPARATION OF 3-(2-HYDROXY-5-SUBSTITUTED PHENYL)-3-PHENYLPROPYLAMINES, INTERMEDIATES FOR MAKING HYDROXYTOLTERODINE AND FESOTERODINE | LEK PHARMACEUTICALS (SI) | 2016-08-03 | — | — | EP | claimed |
| US-8703996-B2 | Short synthesis of tolterodin, intermediates and metabolites | LEK PHARMACEUTICALS D.D. (SI) | 2014-04-22 | — | — | US | claimed |
| US-20130197082-A1 | SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES | LEK PHARMACEUTICALS D.D. (SI) | 2013-08-01 | — | — | US | claimed |
| EP-2326654-B1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA- OLEFINS USING THE SAME. | SK INNOVATION CO LTD (KR) | 2013-03-20 | — | — | EP | claimed |
| EP-2545024-A1 | SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES | LEK Pharmaceuticals d.d. (SI) | 2013-01-16 | — | — | EP | claimed |
| US-8232359-B2 | Process for preparing ethylene homopolymers or copolymers of ethylene with α-olefin by using the transition metal compound | SK INNOVATION CO., LTD. (KR) | 2012-07-31 | — | — | US | claimed |
| WO-2011110556-A1 | SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES | LEK PHARMACEUTICALS D.D. (SI) | 2011-09-15 | — | — | WO | claimed |
| EP-2364966-A1 | Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine | LEK Pharmaceuticals d.d. (SI) | 2011-09-14 | — | — | EP | claimed |
| EP-2326654-A2 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND - OLEFINS USING THE SAME. | SK Energy Co., Ltd. (KR) | 2011-06-01 | — | — | EP | claimed |
| US-20110098426-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF THE ETHYLENE AND a-OLEFINS USING THE SAME | SK ENERGY CO., LTD. (KR) | 2011-04-28 | — | — | US | claimed |
| US-7928173-B2 | Transition metal catalytic systems and methods for preparing ethylene homopolymers or copolymers of ethylene and α-olefins using the same | SK ENERGY CO., LTD. (KR) | 2011-04-19 | — | — | US | claimed |
| US-20100081776-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND a-OLEFINS USING THE SAME | SABIC SK NEXLENE COMPANY PTE. LTD. (SG) | 2010-04-01 | — | — | US | claimed |
| WO-2010036025-A2 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND α- OLEFINS USING THE SAME. | SK ENERGY CO., LTD. (KR) | 2010-04-01 | — | — | WO | claimed |
| US-6677473-B1 | TREATMENT, PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF THROMBOTIC DISORDERS, UNSTABLE ANGINA OR CANCER | CORVAS INTERNATIONAL INC | 2004-01-13 | — | — | US | claimed |
| WO-2001036351-A2 | PLASMINOGEN ACTIVATOR INHIBITOR ANTAGONISTS RELATED APPLICATIONS | CORVAS INTERNATIONAL, INC. (US) | 2001-05-25 | — | — | WO | claimed |
| US-5776932-A | ANTIALLERGENS, ANTIASTHMATICS, ANTIINFLAMMATORY AGENTS AND MODULATORS | ARZNEIMITTELWERK DRESDEN G.M.B.H. (DE) | 1998-07-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130197082-A1 | SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES | COMT, UGT1A7, PAH | GPR3 1212/4885HTR2A 894/4885NCOR2 3817/4885 |
| US-20100081776-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND a-OLEFINS USING THE SAME | ESR1, AOC3, PPOX | GPR3 3346/4885HTR2A 4630/4885NCOR2 2402/4885 |
| US-20110098426-A1 | TRANSITION METAL CATALYTIC SYSTEMS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF THE ETHYLENE AND a-OLEFINS USING THE SAME | ESR1, AOC3, AOC2 | GPR3 3118/4885HTR2A 4584/4885NCOR2 2350/4885 |
| US-10745372-B2 | Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method | ASH2L, MLLT1, FRG1 | GPR3 3887/4885HTR2A 2703/4885NCOR2 940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.